Investor Announcements - 2015
|
| ||
| ||
| ||
EKF Diagnostics Holdings plc has received a preliminary approach regarding a possible acquisition. | ||
| ||
Proposal received to offer $115-$125m in cash for POC business. | ||
| ||
EKF Diagnostics Holdings plc announced on 2 April 2015 that the Board of Directors had initiated a strategic review headed by a Committee of the Non-Executive Directors of EKF. | ||
| ||
EKF Diagnostics Holdings plc announces conclusion of Strategic Review. | ||
| ||
EKF Diagnostics Holdings plc provides the following trading update for the six months ending 30 June 2015. | ||
| ||
| ||
EKF Diagnostics, the global in vitro diagnostics company, announces the international launch of the Altair™ 240 clinical chemistry analyzer at the American Association for Clinical Chemistry’s (AACC) Annual Meeting and Clinical Lab Expo in Atlanta, Ga, 26-30 July. | ||
| ||
EKF Diagnostics, the global in vitro diagnostics company, announces the appointment of a number of senior personnel to key new roles to drive new product introductions. | ||
| |||||||||||
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.